St John of God Health Care will stop operating maternity services at its Bunbury Hospital next month, citing a staff shortage in delivering private obstetric care in regional areas.
MSWA has broken ground on its long-awaited 24-hour care facility in Shenton Park, marking the start of a major project for the not-for-profit organisation.
Mental health services, including crisis support, will go virtual in a WA-first co-response model announced in a tranche of state government health budget commitments.
St John of God has proposed to build a five-storey private hospital in its Midland precinct, estimated to cost almost $160 million, to replace the services acquired by the state government.
Hesperia will start construction of a four-storey orthopaedic hospital, estimated to cost $69 million, by the end of the year after receiving unanimous support from a development panel.
A new co-ordinated emergency and medical care operations centre will be established in the old Telstra Exchange tower, to be operational by the end of the year.
Shares in Argenica Therapeutics were down by 13 per cent on Friday morning, despite the biotechnology technology announcing it would raise $12 million in order to complete its second phase trial of its ARG 007 drug in ischaemic stroke patients.
A joint venture between Multiplex Constructions and Perkins Builders has been contracted for main works of the Bunbury Regional Hospital's redevelopment project.
WA Liberal leader Libby Mettam has slammed the state government for inaction on potentially flammable cladding at Fiona Stanley Hospital identified five years ago.
The Child Development Service will go through an expansion and staff increase as part of a $39 million funding boost to ease “unprecedented” demand for the service.
St John of God Health Care will expand its Murdoch hospital to include a five-storey mental health facility, after the state’s peak planning body greenlit its $98.6 million proposal.
PYC Therapeutics is rattling the tin for up to $74.6 million to fund the progress of its medical drug trials, including for blinding eye and polycystic kidney diseases.